{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:40:05Z","timestamp":1744710005904,"version":"3.40.4"},"reference-count":47,"publisher":"Begell House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Fibromyalgia (FM) is a chronic condition marked by widespread pain, fatigue, and other debilitating symptoms, affecting 2-4&amp;#37; of the population, predominantly women. Diagnosing FM is challenging due to its complex symptoms and lack of specific biomarkers. To characterize the gene expression profile in FM and identify target genes and potential biomarkers for FM. The RNA-sequencing data (RNA-seq) from FM patients and healthy controls were downloaded from the GEO database and analyzed in R to detect differentially expressed genes (DEGs). A weighted gene co-expression network analysis (WGCNA) was conducted on all genes to identify FM-associated modules. The intersection of DEGs with key module genes was used to build four machine learning models, with the top features from the support vector machine model tested for drug sensitivity to identify therapeutic targets. Expression of the top five genes was validated using real-time quantitative polymerase chain reaction and Western blotting. We identified 1599 DEGs between FM and healthy control. WGCNA revealed that 267 genes in the pink module were correlated with FM. The overlapped 76 key DEGs allow us to build machine-learning models that predict FM with high accuracy (area under the curve &amp;#61; 0.877). The top five genes that are contributing to the model were tested for potential drug targets. Drug sensitivity analysis showed a strong correlation between HAVCR1 and 10 tyrosine kinase inhibitors among the top gene-drug relationships. This study identified key FM-associated gene targets, demonstrating that their expression profiles can be used to predict FM risk. Our findings provide insights into the molecular mechanisms of FM and highlight potential therapeutic targets for improved FM treatment.\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025057263","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:10:41Z","timestamp":1739293841000},"page":"39-53","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of Target Genes for Fibromyalgia through Bioinformatics Analysis"],"prefix":"10.1615","volume":"35","author":[{"given":"Mao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Botao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Clauw DJ. Fibromyalgia: A clinical review. JAMA. 2014;311(15):1547-55.","DOI":"10.1001\/jama.2014.3266"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Berwick R, Barker C, Goebel A. The diagnosis of fibromyalgia syndrome. Clin Med. 2022;22(6):570-4.","DOI":"10.7861\/clinmed.2022-0402"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891.","DOI":"10.3390\/ijms22083891"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Zetterman T, Markkula R, Kalso E. Elevated highly sensitive C-reactive protein in fibromyalgia associates with symptom severity. Rheumatol Adv Pract. 2022;6(2):rkac053.","DOI":"10.1093\/rap\/rkac053"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Haliloglu S, Carlioglu A, Sahiner E, Karaaslan Y, Kosar A. Mean platelet volume in patients with fibromyalgia. Z Rheumatol. 2014;73(8):742-5.","DOI":"10.1007\/s00393-013-1330-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Akturk S, Buyukavci R. Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clin Rheumatol. 2017;36(8):1885-9.","DOI":"10.1007\/s10067-017-3647-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"El-Sawy EA, Abdul Hakim MM, El-Zohiery A, Salama SM. Significance of inflammatory markers in primary Fibromyalgia syndrome and their relation in assessing the disease severity. Egypt J Immunol. 2024;31(1):67-74.","DOI":"10.55133\/eji.310108"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hsu WH, Han DS, Ku WC, Chao YM, Chen CC, Lin YL. Metabolomic and proteomic characterization of sng and pain phenotypes in fibromyalgia. Eur J Pain. 2022;26(2):445-62.","DOI":"10.1002\/ejp.1871"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Flodin P, Martinsen S, Mannerkorpi K, Lofgren M, Bileviciute-Ljungar I, Kosek E, Fransson P. Normalization of aberrant resting state functional connectivity in fibromyalgia patients following a three month physical exercise therapy. Neuroimage Clin. 2015;9:134-9.","DOI":"10.1016\/j.nicl.2015.08.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ramirez-Tejero JA, Duran-Gonzalez E, Martinez-Lara A, Lucena Del Amo L, Sepulveda I, Huancas-Diaz A, Carvajal M, Cotan D. Microbiota and mitochondrial sex-dependent imbalance in fibromyalgia: A pilot descriptive study. Neurol Int. 2023;15(3):868-80.","DOI":"10.3390\/neurolint15030055"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Farag HM, Yunusa I, Goswami H, Sultan I, Doucette JA, Eguale T. Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: A systematic review and network meta-analysis. JAMA Netw Open. 2022;5(5):e2212939.","DOI":"10.1001\/jamanetworkopen.2022.12939"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Pereira V, Goudet C. Emerging trends in pain modulation by metabotropic glutamate receptors. Front Mol Neurosci. 2018;11:464.","DOI":"10.3389\/fnmol.2018.00464"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Beyreuther BK, Geis C, Stohr T, Sommer C. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology. 2007;52(5):1312-7.","DOI":"10.1016\/j.neuropharm.2007.01.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020;2020:6541798.","DOI":"10.1155\/2020\/6541798"},{"key":"16","unstructured":"Zhang L, Zhu J, Chen Y, Zhao J. Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val(1)(5)(8)met and fibromyalgia. Int J Clin Exp Pathol. 2014;7(12): 8489-97."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Przybylowicz PK, Sokolowska KE, Rola H, Wojdacz TK. DNA methylation changes in blood cells of fibromyalgia and chronic fatigue syndrome patients. J Pain Res. 2023;16:4025-36.","DOI":"10.2147\/JPR.S439412"},{"key":"18","unstructured":"Jones KD, Gelbart T, Whisenant TC, Waalen J, Mondala TS, Ikl\u00ef\u00bf\u00bd&copy; DN, Salomon DR, Bennett RM, Kurian SM. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S89-98."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mohapatra G, Dachet F, Coleman LJ, Gillis B, Behm FG. Identification of unique genomic signatures in patients with fibromyalgia and chronic pain. Sci Rep. 2024;14(1):3949.","DOI":"10.1038\/s41598-024-53874-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","DOI":"10.1093\/nar\/gkv007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Chen H, Boutros PC. VennDiagram: A package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform. 2011;12:35.","DOI":"10.1186\/1471-2105-12-35"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284-7.","DOI":"10.1089\/omi.2011.0118"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kuhn M. Building predictive models in R using the caret package. J Stat Softw. 2008;28(5):1-26.","DOI":"10.18637\/jss.v028.i05"},{"key":"25","unstructured":"Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2(3):18-22."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Karatzoglou A SA, Hornik K, Zeileis A. kernlab - An S4 package for kernel methods in R. J Stat Softw. 2004;11(9):1-20.","DOI":"10.18637\/jss.v011.i09"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York: Association for Computing Machinery; 2016. p. 785-794.","DOI":"10.1145\/2939672.2939785"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.","DOI":"10.1186\/1471-2105-12-77"},{"key":"29","unstructured":"Biecek P. DALEX: Explainers for complex predictive models in R. J Mach Learn Res. 2018;19(84):1-5."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944-52.","DOI":"10.1002\/art.20042"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Gerdle B, Bjork J, Coster L, Henriksson K, Henriksson C, Bengtsson A. Prevalence of widespread pain and associations with work status: A population study. BMC Musculoskelet Disord. 2008;9:102.","DOI":"10.1186\/1471-2474-9-102"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.","DOI":"10.1186\/1471-2474-8-27"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Hauser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B. Fibromyalgia. Nat Rev Dis Primers. 2015;1(1):15022.","DOI":"10.1038\/nrdp.2015.22"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19-28.","DOI":"10.1002\/art.1780380104"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: The possible role of resistance to thyroid hormone. Med Hypotheses. 2003;61(2):182-9.","DOI":"10.1016\/S0306-9877(02)00294-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Akkus S, Delibas N, Tamer MN. Do sex hormones play a role in fibromyalgia? Rheumatology. 2000;39(10):1161-3.","DOI":"10.1093\/rheumatology\/39.10.1161"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Hernandez-Leon A, De la Luz-Cuellar YE, Granados-Soto V, Gonzalez-Trujano ME, Fernandez-Guasti A. Sex differences and estradiol involvement in hyperalgesia and allodynia in an experimental model of fibromyalgia. Horm Behav. 2018;97:39-46.","DOI":"10.1016\/j.yhbeh.2017.10.011"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Okifuji A, Turk DC. Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain. 2006;7(11):851-9.","DOI":"10.1016\/j.jpain.2006.04.005"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med. 1998;104(3):227-31.","DOI":"10.1016\/S0002-9343(97)00351-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Sola J, Casanueva FF, Garcia-Fructuoso F, Poca-Dias V, Izquierdo JP, Puig-Domingo M. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab. 2010;95(9):4331-7.","DOI":"10.1210\/jc.2010-0061"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Nanda S. Viral hepatitis: HAVCR1 variants underlie susceptibility to liver failure in hepatitis A infection-an unlikely link with allergy. Nat Rev Gastroenterol Hepatol. 2011;8(5):244.","DOI":"10.1038\/nrgastro.2011.42"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Garcia-Lozano JR, Abad C, Escalera A, Torres B, Fernandez O, Garcia A, Sanchez-Roman J, Sabio JM, Ortego-Centeno N, Raya-Alvarez E, Nunez-Roldan A, Martin J, Gonz\u00c3\u00a1lez-Escribano MF. Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases. Hum Genet. 2010;128(2):221-9.","DOI":"10.1007\/s00439-010-0844-1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Hu YD, Wu K, Liu YJ, Zhang Q, Shen H, Ji J, Fang D, Xi SY. LY6\/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment. Biol Direct. 2023;18(1):72.","DOI":"10.1186\/s13062-023-00424-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Neupane N, Rajendran J, Kvist J, Harjuhaahto S, Hu B, Kinnunen V, Yang Y, Nieminen AI, Tyynismaa H. Inter-organellar and systemic responses to impaired mitochondrial matrix protein import in skeletal muscle. Commun Biol. 2022;5(1):1060.","DOI":"10.1038\/s42003-022-04034-z"},{"key":"45","unstructured":"Cordero MD, de Miguel M, Carmona-Lopez I, Bonal P, Campa F, Moreno-Fernandez AM. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett. 2010;31(2):169-73."},{"key":"46","doi-asserted-by":"crossref","unstructured":"Casteels M, Sniekers M, Fraccascia P, Mannaerts GP, Van Veldhoven PP. The role of 2-hydroxyacyl-CoA lyase, a thiamin pyrophosphate-dependent enzyme, in the peroxisomal metabolism of 3-methyl-branched fatty acids and 2-hydroxy straight-chain fatty acids. Biochem Soc Trans. 2007;35(Part 5):876-80.","DOI":"10.1042\/BST0350876"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X, Gao H, Ouyang C, Dery KJ, Le K, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE. Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS One. 2013;8(6):e65033.","DOI":"10.1371\/journal.pone.0065033"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Qiu Y, Zhang TJ, Meng LB, Cheng XT, Hua Z. Bioinformatics analysis of gene and microRNA targets for fibromyalgia. Clin Exp Rheumatol. 2021;39(1):21-31.","DOI":"10.55563\/clinexprheumatol\/iitbcp"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/11a8a435240b2214\/CRE-57263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:00:39Z","timestamp":1744707639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,66977548085bae20,11a8a435240b2214.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025057263","relation":{},"ISSN":["1045-4403"],"issn-type":[{"type":"print","value":"1045-4403"}],"subject":[],"published":{"date-parts":[[2025]]}}}